Evidence map›Paper›PMID 38488051›Full record

ReviewJournal of clinical research in pediatric endocrinology2024

Current Management of Type 1 Diabetes in Children: Guideline-based Expert Opinions and Recommendations

Şükrü Hatun, Tuğba Gökçe, Ecem Can, Elif Eviz, Kağan Ege Karakuş, Carmel Smart, Ragnar Hanas, Gül Yeşiltepe Mutlu

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical research in pediatric endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Şükrü HatunKoç University Hospital, Department of Pediatric Endocrinology and Diabetes, İstanbul, TurkeyORCID 0000-0003-1633-9570
Tuğba GökçeKoç University Hospital, Department of Pediatric Endocrinology and Diabetes, İstanbul, TurkeyORCID 0000-0003-3781-3892
Ecem CanKoç University Hospital, Department of Pediatric Endocrinology and Diabetes, İstanbul, TurkeyORCID 0000-0001-6312-6004
Elif EvizKoç University Hospital, Department of Pediatric Endocrinology and Diabetes, İstanbul, TurkeyORCID 0000-0002-8889-6811
Kağan Ege KarakuşKoç University Faculty of Medicine, Department of Pediatric Endocrinology and Diabetes, İstanbul, TurkeyORCID 0000-0002-8552-5206
Carmel SmartJohn Hunter Children’s Hospital, Clinic of Endocrinology, Newcastle, AustraliaORCID 0000-0003-3104-8800
Ragnar HanasNU Hospital Group, Uddevalla Hospital, Uddevalla, and Sahlgrenska Academy, Institute of Clinical Sciences, University of Gothenburg, Department of Pediatrics, Gothenburg, SwedenORCID 0000-0001-8372-030X
Gül Yeşiltepe MutluKoç University Hospital, Department of Pediatric Endocrinology and Diabetes, İstanbul, TurkeyORCID 0000-0003-3919-7763
Koç University · TRJohn Hunter Children's Hospital · AUUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Successful management of type 1 diabetes (T1D) requires not only optimal glycemic outcomes, but also a holistic approach that encompasses all aspects of life and recommendations to address needs. Current goals include optimal glycemic values, quality of life and life expectancy similar to peers, prevention of long-term complications, prevention of severe hypoglycemia as far as possible and facilitation of glucose management. The International Society for Pediatric and Adolescent Diabetes (ISPAD) has been updating its guidelines for diabetes care every four years since 1995, covering more and more topics. For optimal metabolic outcomes, diabetes teams need to follow these current recommendations, adapt them to their clinical practice and provide guidance to people with T1D and their families. In this review, in the light of ISPAD 2018-2022 guidelines and clinical experiences, “10 Key Recommendations”, emphasizing the importance of teamwork and the use of technology, current T1D treatment is described for practical applications.

Indexed as

Diabetes Mellitus, Type 1Practice Guidelines as TopicAdolescentChildDisease ManagementHumansHypoglycemic AgentsQuality of LifeHypoglycemic AgentsCarbohydrate countingdiabetes campglucose targetglycemic outcomeHbA1cinsulin carbohydrate ratioinsulin sensitivity

Identifiers

PMID38488051
PMCPMC11590761
OpenAlexW4392851099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.